<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-09-03T10:35:59Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/86450BB4-239E-4893-8DE7-7F01BB099909" ns1:id="86450BB4-239E-4893-8DE7-7F01BB099909"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/9FDA6B9B-6903-4720-99C6-A20F63B12497" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/2EA20B8C-4C27-470F-A25E-0B6BA5B29369" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/2EA20B8C-4C27-470F-A25E-0B6BA5B29369" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/FF57B174-AD50-461B-B0CC-CFA64DC14C0D" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2021-02-28T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/8BF5F338-7C30-4797-A3AE-C13BACC0CAF9" ns1:rel="FUND" ns1:start="2019-12-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">105759</ns2:identifier></ns2:identifiers><ns2:title>Proof of concept evaluation for a novel colorectal cancer therapeutic</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Study</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>‘MedAnnex is developing a novel oncology therapy based on targeting a protein known as annexin-A1, which is thought to play a role in the development of cancer. This project is a vital step in the development of an innovative cancer therapy with the potential to become a major new drug to improve patient quality of life and extend lives.’</ns2:abstractText></ns2:project>